RE: Official Response from Tiziana about trials05 Jun 2021 10:26
Great work Paul. I was going to simply post that it was carri d out in Brazil therefore outside of the FDA regulatory area but simple message like that would have fallen on deaf ears. You can search the Brazilian hospital where the nasal trial is taking place. Here is the relevant excerpt fro Nov 2020. "...scientific teams at the Harvard Medical School, Santa Casa de Misericórdia de Santos Hospital (Jabaquara, Santos, Brazil) and at Tiziana are closely collaborating to facilitate initiation of this study in expedited time frames. This clinical trial will be coordinated by the team at INTRIALS, a leading, full-service Latin America Clinical Research Organisation, (CRO) based in Sao Paulo City, Brazil. " All the best everyone
Very round numbers Criesagain. Probably placing shares? Still think there's 20-30% to go. If you need the money to fill another lending contract then you obviously sell your assets to fill it. Good luck all
I'm sorry Bluebelly you're usually pretty good but now that is some real nonsense. If you couldn't afford to lose your entire investment in a share you shouldn't have invested, regardless of any dividend (yes AccuStem is a dividend). If you're gambling then the capital out is a problem. If you're investing then it's calculated and sensible. I too would buy as many AccuStem entitlements as I could right now off the whining traders currently present on this board. Perhaps TILS has worn you down BB and you need to move on? By the way, the Board of Directors owe shareholders nothing in any company. All opinions and all the best.